Works citing this work

6 works

Work: Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

1. Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

   Omer Qutaiba B. Allela, Abdulkareem Shareef, S. Renuka Jyothi +9

   ArticleCAR-T cell therapy researchDiscover Oncology20250 citations

   ABIABI:AkademIndex/openalex/2025.article.001466

2. Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers

   Minzhi Huang, Ahmad Ewadi, Nazli Servatian +6

   Review articleCRISPR and Genetic EngineeringCritical Reviews in Oncology/Hematology20250 citations

   ABIABI:AkademIndex/openalex/2025.review-article.000099

3. Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies

   Omer Qutaiba B. Allela, Ali Fawzi Al-Hussainy, Gaurav Sanghvi +9

   Review articleCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 citations

   ABIABI:AkademIndex/openalex/2025.review-article.000143

4. Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers

   Ghaleb Oriquat, Waleed K. Abdulsahib, Sajida Hussein Ismael +6

   ArticleImmune Cell Function and InteractionAnnals of Hematology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.005653

5. CAR‐NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer

   Xiao Lyu, Na Zhu, Ruijuan Guo +1

   ArticleCAR-T cell therapy researchCell Biology International20260 citations

   ABIABI:AkademIndex/openalex/2026.article.012258

6. Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities

   Фарида Муиновна Хамидова, Zarina Babaeva, Khasan Jafarov +6

   ArticleImmunotherapy and Immune ResponsesClinical & Translational Oncology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.025804